BreastScreen Australia national data by factors of interest for risk-based screening: routinely reported data and opportunities for enhancement.
BreastScreen
breast cancer
risk-based screening
screening outcomes
Journal
Australian and New Zealand journal of public health
ISSN: 1753-6405
Titre abrégé: Aust N Z J Public Health
Pays: United States
ID NLM: 9611095
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
revised:
01
10
2021
received:
01
03
2021
accepted:
01
11
2021
pubmed:
4
2
2022
medline:
8
4
2022
entrez:
3
2
2022
Statut:
ppublish
Résumé
There is growing interest in more risk-based approaches to breast cancer screening in Australia. This would require more detailed reporting of BreastScreen data for factors of interest in the assessment and monitoring of risk-based screening. This review assesses the current and potential availability and reporting of BreastScreen data for this purpose. We systematically searched governmental BreastScreen reports and peer-reviewed literature to assess current and potential availability of outcomes for predetermined factors including breast cancer risk factors and factors important for implementing, monitoring or evaluating risk-based screening. Outcomes evaluated were BreastScreen Performance Indicators routinely included in BreastScreen Australia monitoring reports, and key tumour characteristics. All outcomes were reported annually by age group, except for tumour hormone receptor status, nodal involvement and grade. Screening participation was reported nationally for many factors important for risk-based screening; other reporting was ad hoc or unavailable. There is potential to build on BreastScreen's existing high-quality national data collection and reporting systems to inform and support risk-based breast screening. Enhanced BreastScreen data collection and reporting would improve the evidence base and support evaluation of risk-based screening and improve the detail available for benchmarking any future changes to the program.
Identifiants
pubmed: 35112749
doi: 10.1111/1753-6405.13203
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
230-236Subventions
Organisme : Australian Government Department of Health
ID : 2000004049
Informations de copyright
© 2022 The Authors.
Références
Australian Institute of Health and Welfare. BreastScreen Australia Monitoring Report 2020. Canberra (AUST): AIHW; 2020.
Nickson C, Mason KE, English DR, Kavanagh AM. Mammographic screening and breast cancer mortality: A case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012;21(9):1479-88.
Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: Evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat. 2008;108(3):409-16.
Elder K, Nickson C, Pattanasri M, Cooke S, Machalek D, Rose A, et al. Treatment intensity differences after early-stage breast cancer (ESBC) diagnosis depending on participation in a screening program. Ann Surg Oncol. 2018;25(9):2563-72.
BreastScreen NSW. Breast Cancer and Family History. Sydney (AUST): Cancer Institute New South Wales; 2020 [cited 2020 December 10]. Available from: https://www.breastscreen.nsw.gov.au/about-breast-cancer/breast-cancer-and-family-history/
BreastScreen SA. The Impact of BreastScreen SA, 20 Year Report 1989-2008: With Trend Data for 1989-2004. Adelaide (AUST): South Australian Department of Health; 2010.
BreastScreen Tasmania. What Does it Mean for Me if Someone in My Family has had Breast Cancer? Hobart (AUST): Tasmanian Department of Health; 2020 [cited 2020 December 10]. Available from: https://www.breastscreen.nsw.gov.au/about-breast-cancer/breast-cancer-and-family-history/
BreastScreen Victoria. When Should GPs Recommend Screening? Melbourne (AUST): BreastScreen Victoria; 2020 [cited 2020 December 10]. Available from: https://www.breastscreen.org.au/health-professionals/when-should-gps-recommend-screening/
BreastScreen WA. Family History of Breast Cancer. Perth (AUST): Western Australian Department of Health; 2019 [cited 2020 December 10]. Available from: https://www.breastscreen.health.wa.gov.au/Breast-health/Family-history-of-breast-cancer
Department of Health and Ageing. Evaluation of the BreastScreen Australia Program - Evaluation Final Report - June 2009. Canberra (AUST): Government of Australia; 2009.
The Royal Australian College of General Practitioners. Guidelines for Preventive Activities in General Practice. 9th ed. East Melbourne (AUST): RACGP; 2016.
Cancer Institute NSW. Breast Cancer (High Risk with No Family History of Ovarian Cancer) - Risk Management (Female). Sydney (AUST): State Government of New South Wales; 2021 [cited 2021 January 21]. Available from: https://www.eviq.org.au/cancer-genetics/adult/risk-management/743-breast-cancer-high-risk-with-no-family-histor#history
Australian Government Department of Health. Medicare Benefits Schedule. Canberra (AUST): Government of Australia; 2020 [cited 2021 January 21]. Available from: http://www.mbsonline.gov.au/internet/mbsonline/publishing.nsf/Content/Home
Nickson C, Velentzis LS, Brennan P, Mann GB, Houssami N. Improving breast cancer screening in Australia: A public health perspective. Public Health Res Pract. 2019;29(2):2921911.
Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI Screening for women with extremely dense breast tissue. N Engl J Med. 2019;381(22):2091-102.
Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, et al. MR Imaging as an additional screening modality for the detection of breast cancer in women aged 50-75 years with extremely dense breasts: The DENSE Trial Study Design. Radiology. 2015;277(2):527-37.
Esserman LJ. The WISDOM Study: Breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017;3:34.
MyPeBS. MyPeBS; Personalised Breast Screening. Paris (FRC): Unicancer; 2018 [cited 2021 January 21]. Available from: https://www.mypebs.eu/
Paci E, Mantellini P, Giorgi Rossi P, Falini P, Puliti D. [Tailored Breast Screening Trial (TBST)]. Epidemiol Prev. 2013;37(4-5):317-27.
Cancer Council Australia. Roadmap for Optimising Screening in Australia - Breast. Sydney (AUST): Cancer Council; 2020 [cited 2021 October 12]. Available from: https://www.cancer.org.au/about-us/policy-and-advocacy/early-detection-policy/breast-cancer-screening/optimising-early-detection
Tricco A, Lillie E, Zarin W, O'Brien K, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018;169(7):467-73.
Australian Institute of Health and Welfare. BreastScreen Australia Data Dictionary. Version 1.2. Canberra (AUST): AIHW; 2019.
Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst. 2010;102(21):1618-27.
Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst. 2015;107(5).
Australian Institute of Health and Welfare. Reports & data. Canberra (AUST): AIHW; 2020. [cited 2020 October 9]. Available from: https://www.aihw.gov.au/reports-data
Australian Government Department of Health. Cancer. Canberra (AUST): Government of Australia; 2020. [cited 2020 October 9]. Available from: https://www.health.gov.au/health-topics/cancer
Australian Institute of Health and Welfare. BreastScreen Reference Database. Canberra (AUST): AIHW; 2019.
Australian Institute of Health and Welfare. BreastScreen Australia Monitoring Report 2005-2006. Canberra (AUST): AIHW; 2009.
Australian Institute of Health and Welfare. Analysis of Breast Cancer Outcomes and Screening Behaviour for BreastScreen Australia. Canberra (AUST): AIHW; 2018.
Roder D, Webster F, Zorbas H, Sinclair S. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia. Asian Pac J Cancer Prev. 2012;13(1):147-55.
Roder DM, Ward GH, Farshid G, Gill PG, BreastScreen Australia National Quality Management C. Influence of service characteristics on high priority performance indicators and standards in the BreastScreen Australia program. Asian Pac J Cancer Prev. 2014;15(14):5901-8.
Australian Institute of Health and Welfare. Data Tables: BreastScreen Australia Monitoring Report 2020 - Indicator 1. Canberra (AUST): AIHW; 2020.
Australian Institute of Health and Welfare. Data Tables: BreastScreen Australia Monitoring Report 2021 - Indicator 1: Participation Supplementary Data Tables. Canberra (AUST): AIHW; 2021.
Canadian Partnership Against Cancer. Breast Cancer Screening in Canada: Monitoring and Evaluation of Quality Indicators - Results Report, January 2011 to December 2012. Toronto (CAN): CPAC; 2017.
Randall D, Morrell S, Taylor R, Hung WT. Annual or biennial mammography screening for women at a higher risk with a family history of breast cancer: Prognostic indicators of screen-detected cancers in New South Wales, Australia. Cancer Causes Control. 2009;20(5):559-66.
Beckmann KR, Farshid G, Roder DM, Hiller JE, Lynch JW. Impact of hormone replacement therapy use on mammographic screening outcomes. Cancer Causes Control. 2013;24(7):1417-26.
Noguchi N, Marinovich ML, Wylie EJ, Lund HG, Houssami N. Screening outcomes by risk factor and age: Evidence from BreastScreen WA for discussions of risk-stratified population screening. Med J Aust. 2021;215(8):359-65.
BreastScreen Victoria. Annual Statistical Report Incorporating BreastScreen Victoria Research and Evaluation Report. Melbourne (AUST): BreastScreen Victoria; 2002.
Bennett I, Tourani S, Cockburn L, Reasbeck J, Grobbelaar N, Dann S, et al. Breast cancer screening in women at high risk of hereditary breast cancer: An Australian experience. ANZ J Surg. 2021;91(4):685-90.
Ciatto S, Visioli C, Paci E, Zappa M. Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004;90(2):393-6.
Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, et al. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010;28(24):3830-7.
Kerlikowske K, Zhu W, Hubbard RA, Geller B, Dittus K, Braithwaite D, et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med. 2013;173(9):807-16.
Australian Goverment Department of Health. BreastScreen Australia - Position Statement on Breast Density and Screening. Canberra (AUST): Government of Australia; 2020.
BreastScreen WA. Dense Breasts. Perth (AUST): Western Australian Department of Health; 2019.
Kavanagh AM, Byrnes GB, Nickson C, Cawson JN, Giles GG, Hopper JL, et al. Using mammographic density to improve breast cancer screening outcomes. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2818-24.
Wengert GJ, Helbich TH, Kapetas P, Baltzer PA, Pinker K. Density and tailored breast cancer screening: practice and prediction - an overview. Acta Radiol Open. 2018;7(9):2058460118791212.
Conant EF, Sprague BL, Kontos D. Beyond BI-RADS density: A call for quantification in the breast imaging clinic. Radiology. 2018;286(2):401-4.
Seely JM, Peddle SE, Yang H, Chiarelli AM, McCallum M, Narasimhan G, et al. Breast density and risk of interval cancers: The effect of annual versus biennial screening mammography policies in Canada. Can Assoc Radiol J. 2021:8465371211027958. doi: 10.1177/08465371211027958.
Screening and Immunisations Team - National Health Service. Breast Screening Programme England, 2018-19 [NS]. London (UK): NHS Digital; 2020.
Cancer Australia. Aboriginal and Torres Strait Islander Identification in National Cancer Data. Sydney (AUST): Cancer Australia; 2021[cited 2021 October 20]. Available from: https://ncci.canceraustralia.gov.au/aboriginal-and-torres-strait-islander-identification-national-cancer-data
Cancer Australia. Study of Breast Cancer Screening Characteristics and Breast Cancer Survival in Aboriginal and Torres Strait Islander Women of Australia. Sydney (AUST): Cancer Australia; 2012.